secwatch.observer — SEC 8-K summary
======================================

Issuer:     QuidelOrtho Corp (QDEL)
CIK:        0001906324
Form:       8-K
Filed at:   2024-11-08T23:59:59+00:00
Accession:  0001906324-24-000051
Event type: leadership
Sentiment:  negative
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

QuidelOrtho terminates EVP CCO and EVP COO; appoints Philip McLellan as COO
---------------------------------------------------------------------------

- Terminated Michael S. Iskra (EVP & CCO) and Robert J. Bujarski (EVP & COO), effective Nov 15, 2024.
- Appointed Philip McLellan as Chief Operations Officer, effective Nov 15, 2024.
- McLellan previously SVP of Operations since Nov 2020; prior Thermo Fisher and Toyota.
- He will enter standard Severance/Change in Control and Indemnification agreements.
- No family relationships or related-party transactions disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1906324/000190632424000051/0001906324-24-000051-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1906324/000190632424000051/qdel-20241107.htm
  HTML page:      https://secwatch.observer/filing/0001906324-24-000051

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer